查看更多>>摘要:By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News-From Washington, D.C., NewsRx journalists report that a patent application by the inventors ABBOTT, Charles Wilbur (San Leandro, CA, US); BOYLE, Sean Michael (San Leandro, CA, US); CHEN, Richard (Menlo Park, C A, US); DEA, Steven (Mountain View, CA, US); LEVY, Eric (Newark, CA, US); MELLAC HERUVU, Dattatreya (Union City, CA, US); PYKE, Rachel Marty (Oakland, CA, US); W EST, John (Cupertino, CA, US); ZHANG, Simo V. (Union City, CA, US), filed on Apr il 21, 2022, was made available online on June 6, 2024. No assignee for this patent application has been made. News editors obtained the following quote from the background information suppli ed by the inventors: "Immune checkpoints generally refer to a set of inhibitory pathways hardwired into the immune system, which regulate the duration and ampli tude of physiological immune responses. When activated, the immune checkpoint mo lecules (e.g., PD-1) suppresses the immune system in order to prevent it from at tacking cells indiscriminately. Although immune checkpoints are generally effect ive, tumor cells may manipulate such mechanism to prevent the immune system from eliminating tumor cells.